{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:00:39Z","timestamp":1761292839899,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.07.123","type":"journal-article","created":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T17:21:48Z","timestamp":1313256108000},"page":"8429-8437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Investigations of porcine circovirus type 1 (PCV1) in vaccine-related and other cell lines"],"prefix":"10.1016","volume":"29","author":[{"given":"Hailun","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Shaheduzzaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhanya K.","family":"Willliams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arifa S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.07.123_bib0005","first-page":"153","article-title":"Characterization of papovavirus-and picornavirus-like particles in permanent pig kidney cell lines","volume":"226","author":"Tischer","year":"1974","journal-title":"Zentralbl Bakteriol Orig A"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.07.123_bib0010","first-page":"431","article-title":"Porcine circovirus antigens in PK-15 cell line (ATCC CCL-33) and evidence of antibodies to circovirus in Canadian pigs","volume":"53","author":"Dulac","year":"1989","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaccine.2011.07.123_bib0015","series-title":"Virus taxonomy: eighth report of the international committee on taxonomy of viruses","first-page":"327","article-title":"Circoviridae","author":"Todd","year":"2005"},{"issue":"January (5844)","key":"10.1016\/j.vaccine.2011.07.123_bib0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/295064a0","article-title":"A very small porcine virus with circular single-stranded DNA","volume":"295","author":"Tischer","year":"1982","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.07.123_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01310989","article-title":"Replication of porcine circovirus: induction by glucosamine and cell cycle dependence","volume":"96","author":"Tischer","year":"1987","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2011.07.123_bib0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1743-422X-6-60","article-title":"Replication of porcine circoviruses","volume":"6","author":"Faurez","year":"2009","journal-title":"Virol J"},{"issue":"8","key":"10.1016\/j.vaccine.2011.07.123_bib0035","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/BF01322669","article-title":"Presence of antibodies reacting with porcine circovirus in sera of humans, mice, and cattle","volume":"140","author":"Tischer","year":"1995","journal-title":"Arch Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.123_bib0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/BF01309961","article-title":"Distribution of antibodies to porcine circovirus in swine populations of different breeding farms","volume":"140","author":"Tischer","year":"1995","journal-title":"Arch Virol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.07.123_bib0045","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/j.1537-2995.2006.01003.x","article-title":"Resistance of porcine circovirus and chicken anemia virus to virus inactivation procedures used for blood products","volume":"46","author":"Welch","year":"2006","journal-title":"Transfusion"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2011.07.123_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1439-0450.1994.tb00201.x","article-title":"Some biological and physico-chemical properties of porcine circovirus","volume":"41","author":"Allan","year":"1994","journal-title":"J Vet Med B"},{"key":"10.1016\/j.vaccine.2011.07.123_bib0055","article-title":"Part 6, Inactivation methods grouped by virus","volume":"June Suppl","author":"Sofer","year":"2003","journal-title":"BioPharm Int"},{"year":"2011","author":"Code of Federal Regulations","series-title":"Title 9, animal and animal products (current year): part 113.53, requirements for ingredients of animal origin used for production of biologics","key":"10.1016\/j.vaccine.2011.07.123_bib0060"},{"year":"2010","author":"Center for Biologics Evaluation and Research","series-title":"Guidance for industry: characterization and qualification of cell substrates and other biological materials used in the production of viral vccines for infectious disease indications","key":"10.1016\/j.vaccine.2011.07.123_bib0065"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.07.123_bib0070","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1128\/JVI.02690-09","article-title":"Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus","volume":"84","author":"Victoria","year":"2010","journal-title":"J Virol"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2011.07.123_bib0075","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.vaccine.2010.11.028","article-title":"Analysis of porcine circovirus type 1 detected in Rotarix vaccine","volume":"29","author":"Baylis","year":"2011","journal-title":"Vaccine"},{"unstructured":"U S Food and Drug Administration. Update on recommendations for the use of rotavirus vaccines. http:\/\/wwwfdagov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm212140htm [14.05.2010].","key":"10.1016\/j.vaccine.2011.07.123_bib0080"},{"issue":"June (29\u201330)","key":"10.1016\/j.vaccine.2011.07.123_bib0250","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1016\/j.vaccine.2011.04.087","article-title":"Molecular and infectivity studies of porcine circovirus in vaccines","volume":"29","author":"McClenahan","year":"2011","journal-title":"Vaccine"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2011.07.123_bib0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1399-3089.2005.00249.x","article-title":"Ultrastructural alterations in human blood leukocytes induced by porcine circovirus type 1 infection","volume":"12","author":"Arteaga-Troncoso","year":"2005","journal-title":"Xenotransplantation"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2011.07.123_bib0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1399-3089.2004.00134.x","article-title":"Infection studies on human cell lines with porcine circovirus type 1 and porcine circovirus type 2","volume":"11","author":"Hattermann","year":"2004","journal-title":"Xenotransplantation"},{"issue":"3","key":"10.1016\/j.vaccine.2011.07.123_bib0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.12665\/J83.Khan","article-title":"Characterization and qualification of cell substrates for manufacturing viral vaccines in the United States","volume":"8","author":"Khan","year":"2009","journal-title":"Bioprocess J"},{"key":"10.1016\/j.vaccine.2011.07.123_bib0105","first-page":"451","article-title":"Regulatory considerations for raw materials used in biological products","volume":"64","author":"Khan","year":"2010","journal-title":"PDA J Pharm Sci Technol"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2011.07.123_bib0110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.biologicals.2010.02.015","article-title":"Human and animal vaccine contaminations","volume":"38","author":"Pastoret","year":"2010","journal-title":"Biologicals"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.07.123_bib0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0928-0197(98)00042-7","article-title":"The reverse transcriptase activity in cell-free medium of chicken embryo fibroblast cultures is not associated with a replication-competent retrovirus","volume":"11","author":"Khan","year":"1998","journal-title":"J Clin Virol"},{"year":"2005","author":"Gregory","series-title":"Animal genome size database","key":"10.1016\/j.vaccine.2011.07.123_bib0120"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.07.123_bib0125","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/JCM.37.8.2678-2686.1999","article-title":"Sensitive assays for isolation and detection of simian foamy retroviruses","volume":"37","author":"Khan","year":"1999","journal-title":"J Clin Microbiol"},{"year":"2004","author":"Horner","series-title":"Porcine circovirus infection. Australia and New Zealand standard diagnostic procedures","key":"10.1016\/j.vaccine.2011.07.123_bib0130"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2011.07.123_bib0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00762391","article-title":"Optimization of vaccine production for animal health","volume":"15","author":"Noe","year":"1994","journal-title":"Cytotechnology"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.07.123_bib0140","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1354\/vp.36-5-368","article-title":"Ultrastructure of porcine circovirus in persistently infected PK-15 cells","volume":"36","author":"Stevenson","year":"1999","journal-title":"Vet Pathol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.07.123_bib0145","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/BF02618050","article-title":"Concurrent replication of a papovavirus and a C-type virus in the CCL 33 porcine cell line","volume":"15","author":"Tumilowicz","year":"1979","journal-title":"In Vitro"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2011.07.123_bib0150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/01913120500323399","article-title":"Electron microscopy in the diagnosis of BK-polyoma virus infection in the transplanted kidney","volume":"29","author":"Herrera","year":"2005","journal-title":"Ultrastruct Pathol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.07.123_bib0155","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/iai.5.6.961-967.1972","article-title":"Characteristics of a swine papovavirus","volume":"5","author":"Newman","year":"1972","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.07.123_bib0160","first-page":"85","article-title":"Serum lipoprotein studies of humans and hamsters","volume":"12","author":"Blashfield","year":"1981","journal-title":"Micron"},{"unstructured":"Howe B. May 7, 2010: vaccines and related biological products advisory committee meeting: ROTARIX (Rotavirus Vaccine, Live Oral): GSK's PCV1 investigation. http:\/\/www.fda.gov\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/VaccinesandRelatedBiologicalProductsAdvisoryCommittee\/ucm211828.htm; 2010.","key":"10.1016\/j.vaccine.2011.07.123_bib0165"},{"issue":"November (4)","key":"10.1016\/j.vaccine.2011.07.123_bib0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0165-2427(94)90157-0","article-title":"Production, preliminary characterisation and applications of monoclonal antibodies to porcine circovirus","volume":"43","author":"Allan","year":"1994","journal-title":"Vet Immunol Immunopathol"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.07.123_bib0175","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/104063879600800401","article-title":"A sequential study of experimental porcine paramyxovirus (LPMV) infection of pigs: immunostaining of cryostat sections and virus isolation","volume":"8","author":"Allan","year":"1996","journal-title":"J Vet Diagn Invest"},{"issue":"June (26)","key":"10.1016\/j.vaccine.2011.07.123_bib0180","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/vr.146.26.762","article-title":"Serum antibodies to porcine circovirus type 1 and type 2 in pigs with and without PMWS","volume":"146","author":"Rodriguez-Arrioja","year":"2000","journal-title":"Vet Rec"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.07.123_bib0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/104063870001200102","article-title":"Porcine circoviruses: a review","volume":"12","author":"Allan","year":"2000","journal-title":"J Vet Diagn Invest"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2011.07.123_bib0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0378-1135(94)90107-4","article-title":"Infection of leucocyte cell cultures derived from different species with pig circovirus","volume":"41","author":"Allan","year":"1994","journal-title":"Vet Microbiol"},{"year":"2010","author":"U S Food and Drug Administration","series-title":"Update on recommendations for the use of rotavirus vaccines","key":"10.1016\/j.vaccine.2011.07.123_bib0195"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.123_bib0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jama.2010.863","article-title":"FDA: benefits of rotavirus vaccination outweigh potential contamination risk","volume":"304","author":"Kuehn","year":"2010","journal-title":"JAMA"},{"unstructured":"International Conference on Harmonisation. ICH Topics Q5A(R1) \u2013 Viral safety of biotechnology products derived from cell lines of human or animal origin; September 23 1999.","key":"10.1016\/j.vaccine.2011.07.123_bib0205"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.07.123_bib0210","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/nar\/26.7.1628","article-title":"Consensus-degenerate hybrid oligonucleotide primers for amplification of distantly related sequences","volume":"26","author":"Rose","year":"1998","journal-title":"Nucleic Acids Res"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2011.07.123_bib0215","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0888-7543(92)90147-K","article-title":"Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer","volume":"13","author":"Telenius","year":"1992","journal-title":"Genomics"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.07.123_bib0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/fmb.09.120","article-title":"Metagenomics for the discovery of novel human viruses","volume":"5","author":"Tang","year":"2010","journal-title":"Future Microbiol"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2011.07.123_bib0225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.biologicals.2010.01.003","article-title":"Massively parallel sequencing, a new method for detecting adventitious agents","volume":"38","author":"Onions","year":"2010","journal-title":"Biologicals"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.07.123_bib0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/abio.2001.5460","article-title":"A whole genome amplification method to generate long fragments from low quantities of genomic DNA","volume":"300","author":"Kittler","year":"2002","journal-title":"Anal Biochem"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.07.123_bib0235","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrmicro1918","article-title":"Ibis T5000: a universal biosensor approach for microbiology","volume":"6","author":"Ecker","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2011.07.123_bib0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/rmv.532","article-title":"Viral metagenomics","volume":"17","author":"Delwart","year":"2007","journal-title":"Rev Med Virol"},{"issue":"January\u2013February (1)","key":"10.1016\/j.vaccine.2011.07.123_bib0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1051\/vetres:2008048","article-title":"Infectivity of porcine circovirus type 2 DNA in semen from experimentally-infected boars","volume":"40","author":"Madson","year":"2009","journal-title":"Vet Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1101173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:18:00Z","timestamp":1759400280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1101173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":49,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X1101173X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.123","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigations of porcine circovirus type 1 (PCV1) in vaccine-related and other cell lines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}